Pacira BioSciences, Inc. (PCRX)
Operating return on assets (Operating ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | -73,371 | 87,675 | 60,024 | 131,065 | 46,350 |
| Total assets | US$ in thousands | 1,553,520 | 1,574,390 | 1,681,200 | 2,075,350 | 1,274,510 |
| Operating ROA | -4.72% | 5.57% | 3.57% | 6.32% | 3.64% |
December 31, 2024 calculation
Operating ROA = Operating income ÷ Total assets
= $-73,371K ÷ $1,553,520K
= -4.72%
Pacira BioSciences, Inc.'s operating return on assets (operating ROA) shows fluctuations over the years. From December 31, 2020, to December 31, 2021, there was an improvement in operating ROA, increasing from 3.64% to 6.32%. However, by December 31, 2022, the operating ROA decreased to 3.57%, showing a decline in profitability. In the following year, by December 31, 2023, the operating ROA improved again to 5.57%. The most recent data point as of December 31, 2024, indicates a negative operating ROA of -4.72%, which could be a cause for concern as it signifies that the company is operating at a loss in relation to its assets. Overall, the trend in Pacira BioSciences, Inc.'s operating ROA shows some volatility, with periods of improvement and decline in profitability over the years.
Peer comparison
Dec 31, 2024